Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Lymphomes non hodgkinien
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 in Combination With Obinutuzumab (GA101) in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Indolent Non-Hodgkin's Lymphoma